BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 22037554)

  • 1. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
    Wang K; Kan J; Yuen ST; Shi ST; Chu KM; Law S; Chan TL; Kan Z; Chan AS; Tsui WY; Lee SP; Ho SL; Chan AK; Cheng GH; Roberts PC; Rejto PA; Gibson NW; Pocalyko DJ; Mao M; Xu J; Leung SY
    Nat Genet; 2011 Oct; 43(12):1219-23. PubMed ID: 22037554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
    Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
    Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
    Huang SC; Ng KF; Chang IY; Chang CJ; Chao YC; Chang SC; Chen MC; Yeh TS; Chen TC
    PLoS One; 2021; 16(1):e0245356. PubMed ID: 33481850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
    Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
    Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
    Zang ZJ; Cutcutache I; Poon SL; Zhang SL; McPherson JR; Tao J; Rajasegaran V; Heng HL; Deng N; Gan A; Lim KH; Ong CK; Huang D; Chin SY; Tan IB; Ng CC; Yu W; Wu Y; Lee M; Wu J; Poh D; Wan WK; Rha SY; So J; Salto-Tellez M; Yeoh KG; Wong WK; Zhu YJ; Futreal PA; Pang B; Ruan Y; Hillmer AM; Bertrand D; Nagarajan N; Rozen S; Teh BT; Tan P
    Nat Genet; 2012 May; 44(5):570-4. PubMed ID: 22484628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
    Han N; Kim MA; Lee HS; Kim WH
    Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Chen MC; Chao YC; Chuang HC; Liu YJ; Chen TC
    Histopathology; 2020 Aug; 77(2):250-261. PubMed ID: 32343857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
    Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SWI/SNF chromatin remodeling complex alterations in meningioma.
    Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.
    Jones S; Li M; Parsons DW; Zhang X; Wesseling J; Kristel P; Schmidt MK; Markowitz S; Yan H; Bigner D; Hruban RH; Eshleman JR; Iacobuzio-Donahue CA; Goggins M; Maitra A; Malek SN; Powell S; Vogelstein B; Kinzler KW; Velculescu VE; Papadopoulos N
    Hum Mutat; 2012 Jan; 33(1):100-3. PubMed ID: 22009941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique characteristics of
    Kim YS; Jeong H; Choi JW; Oh HE; Lee JH
    Saudi J Gastroenterol; 2017; 23(5):268-274. PubMed ID: 28937020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
    Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
    World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing reveals recurrent somatic mutations and distinct molecular subgroups in gastric cancer in Mizo population, North East India.
    Chakraborty P; Kurkalang S; Ghatak S; Das S; Palodhi A; Sarkar S; Dhar R; Chenkual S; Pachuau L; Zohmingthanga J; Pautu JL; Zomuana T; Lalruatfela ST; Zothanzama J; Kumar NS; Maitra A
    Genomics; 2023 Nov; 115(6):110741. PubMed ID: 37967684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.
    Sun M; Gu Y; Fang H; Shao F; Lin C; Zhang H; Li H; He H; Li R; Wang J; Liu H; Xu J
    Cancer Sci; 2024 Mar; 115(3):905-915. PubMed ID: 38148578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
    Zhou H; Tan S; Li H; Lin X
    Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.
    Le Gallo M; O'Hara AJ; Rudd ML; Urick ME; Hansen NF; O'Neil NJ; Price JC; Zhang S; England BM; Godwin AK; Sgroi DC; ; Hieter P; Mullikin JC; Merino MJ; Bell DW
    Nat Genet; 2012 Dec; 44(12):1310-5. PubMed ID: 23104009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers.
    Kim TM; Jung SH; Kim MS; Baek IP; Park SW; Lee SH; Lee HH; Kim SS; Chung YJ; Lee SH
    J Pathol; 2014 Nov; 234(3):365-74. PubMed ID: 25042771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer.
    Kim JY; Park CK; Noh S; Cheong JH; Noh SH; Kim H
    Gut Liver; 2023 Sep; 17(5):753-765. PubMed ID: 36789575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.